TM London Day One
Wednesday, 6th December 2017
11.40 | Incorporating CRISPR into the pre-clinical testing of TCR-based biologic drug candidates
Dr. María José Oliva Martin is a Senior Scientist in the Preclinical Cell Biology Group at Immunocore Ltd. After graduating in Pharmacy at the University of Seville, she completed an MPhil in Translational Medicine and Therapeutics at the University of Cambridge. She conducted her PhD between the University of Seville, the University of Cambridge and the Karolinska Institute, with a focus on the role of caspases in monocyte activation and its potential in the treatment of inflammatory response syndromes. She first came across CRISPR during her postdoctoral work at the University of Oxford, where she knocked out a differentiation related protein in stem cells. At Immunocore, she has continued in the field of immunotherapy, where she is currently working across different programmes applying CRISPR to specificity testing.